Covid: Under-30s offered alternative to Oxford-AstraZeneca jab

By | April 7, 2021

[unable to retrieve full-text content]A review finds a “plausible” link to rare blood clots, but says the jab remains beneficial for most.
BBC News – Health

Read More:  Quick and Easy CRISPR-Based COVID Test